MMP9 and medullary thyroid gland carcinoma: When applied to the treatment of thyroid cancer, celecoxib decreases the protein and mRNA levels of COX-2, MMP-9, and VEGF in human medullary thyroid cancer TT cells in vitro and in the nude mice model of human medullary thyroid cancer in vivo.